# Medroxyprogesterone

## Provera 5mg

| TAH Drug Code      | [OPRO5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPRO5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Primary & secondary amenorrhea, Dysfunctional bleeding, Endometriosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Secondary menopause: 5-10mg daily for 5-10 days. Abnormal bleeding in the uterus due to hormonal imbalance: 5-10mg daily for 5-10 days from day 16 or day 21 of menstrual cycle.                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Thrombophlebitis, thromboembolic disorders, cerebral apoplexy; liver dysfunction or disease; known or suspected malignancy of breast or genital organs; undiagnosed vag bleeding; pregnancy, missed abortion.                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Nausea; fatigue, depression; acne, hirsutism; breast tenderness, galactorrhea, amenorrhea & anovulation; decreased glucose tolerance; thromboembolic phenomena; anaphylaxis; corticoid-like activity (high doses). Endocrine metabolic: Weight change finding (>5% ) Gastrointestinal: Abdominal pain ( >5% ) Neurologic: Asthenia ( >5% ), Dizziness ( >5% ), Headache ( >5% ) Psychiatric: Feeling nervous ( >5% ) Reproductive: Amenorrhea (>5% ), Break-through bleeding, Disorder of menstruation ( >5% ), Scanty vaginal bleeding |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/medroxyprogesterone-acetate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                              |

